The High-Resolution Three-Dimensional Magnetic Detector System 3D-Magma Accurately Measures Gastric and Small Bowel Motility in People with Type 2 Diabetes with Neuropathy

Abstract

Gastroparesis is an important complication of diabetes. Motility disorders are underdiagnosed and can lead to unexplained hypoglycemia. Currently diagnostic options are limited. All established methods harbor certain disadvantages. The 3D-MAGMA system is capable of reliably measuring gastric and small intestinal motility. The aim of the current study was to determine if 3D-MAGMA is able to detect changes in intestinal motility in people with type 2 diabetes. 18 healthy volunteers and 19 people with type 2 diabetes underwent motility testing by 3D-MAGMA. In the control group the retention time in the stomach was 33.0 [min] compared to 75.3 [min] in the diabetes group. The median time in the duodenum was 12.7 [min] compared to 8.1 [min]. The time for the first 50 cm of the jejunum was 29.9 [min] compared to 28.2 [min]. Discussion and conclusion: 3D-MAGMA is able to detect changes in intestinal motility. Its clinical value might be useful in patients with fluctuating blood glucose levels and unexplained hypoglycemic episodes.

Key words

gastroparesis - gastrointestinal motility - fluctuating blood glucose - neuropathy - gastric emptying - motility disorders

Publikationsverlauf

Eingereicht: 13. Januar 2020
Eingereicht: 08. April 2020

Angenommen: 22. April 2020

Artikel online veröffentlicht:
18. Juni 2020

• References

• 1 Guariguata L, Whiting DR, Hambleton I. et al. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149
• 2 Arredondo A, Aviles R. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems. PLoS One 2015; 10: e0118611 DOI: 10.1371/journal.pone.0118611
• 3 Forouhi NG, Wareham NJ. Epidemiology of diabetes. Medicine (Abingdon, England : UK Ed) 2014; 42: 698-702
• 4 Khavandi K, Amer HBI. et al. Strategies for preventing type 2 diabetes: an update for clinicians. Ther Adv Chronic Dis 2013; 4: 242-261 DOI: 10.1177/
• 5 Ladeia AM, Sampaio RR, Hita MC. et al. Prognostic value of endothelial dysfunction in type 1 diabetes mellitus. World J Diabetes 2014; 5: 601-605
• 6 Chang J, Rayner CK, Jones KL. et al. Diabetic gastroparesis-backwards and forwards. J Gastroenterol Hepatol 2011; 26 (Suppl. 01) 46-57
• 7 Camilleri M, Parkman HP, Shafi MA. et al. Clinical guideline: management of gastroparesis. Am J Gastroenterol 2013; 108: 18-37
• 8 Shin AS, Camilleri M. Diagnostic assessment of diabetic gastroparesis. Diabetes 2013; 62: 2667-2673 DOI: 10.2337/db12-1706/-/DC1
• 9 Tang DM, Friedenberg FK. Gastroparesis: approach, diagnostic evaluation, and management. Dis Mon 2011; 57: 74-101 DOI: 10.1016/j.disamonth.2010.12.007
• 10 Kashyap P, Farrugia G. Diabetic gastroparesis: what we have learned and had to unlearn in the past 5 years. Gut 2010; 59: 1716-1726 DOI: 10.1136/gut.2009.199703
• 11 Tesfaye S, Boulton AJ, Dyck PJ. et al. Diabetic neuropathies: update on definitions, diagnostic criteria, estimation of severity, and treatments. Diabetes Care 2010; 33: 2285-2293
• 12 Huerta-Franco M-R. Effects of metoclopramide on gastric motility measured by short-term bio-impedance. World Journal of Gastroenterology 2009; 15: 4763 DOI: 10.3748/wjg.15.4763
• 13 Ma J, Rayner CKKLJ. et al. Diabetic gastroparesis diagnosis and management. Drugs 2009; 69: 971-986
• 14 Rao SS, Camilleri M, Hasler WL. et al. Evaluation of gastrointestinal transit in clinical practice: position paper of the American and European Neurogastroenterology and Motility Societies. Neurogastroenterol Motil 2011; 23: 8-23
• 15 Bruno G, Lopetuso LR, Ianiro G. et al. 13C-octanoic acid breath test to study gastric emptying time. European Review for Medical and Pharmacological Sciences 2013; 17: 59-64
• 16 Kuo B, McCallum RW, Koch KL. et al. Comparison of gastric emptying of a nondigestible capsule to a radio-labelled meal in healthy and gastroparetic subjects. Aliment Pharmacol Ther 2008; 27: 186-196
• 17 Teramoto H, Shimizu T, Yogo H. et al. Assessment of gastric emptying and duodenal motility upon ingestion of a liquid meal using rapid magnetic resonance imaging. Exp Physiol 2012; 97: 516-524
• 18 Hocke M, Schone U, Richert H. et al. Every slow-wave impulse is associated with motor activity of the human stomach. Am J Physiol Gastrointest Liver Physiol 2009; 296: G709-716
• 19 Jacob VY, Stallmach A, Felber J. Controlled evaluation of a high-resolution three-dimensional magnetic detector system (3D-MAGMA) as a proof of concept - examination of healthy volunteers before and after application of Metoclopramide (MCP). Z Gastroenterol 2016; 54: 556-561
• 20 Young MJ, Boulton AJM, Macleod AF. et al. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150-154
• 21 Richert H, Kosch O, Görnert P. Magnetic monitoring as a diagnostic method for investigating motility in the human digestive system. In: Magnetism in Medicine. Weinheim: Andrae, W. Nowak, H. 2006; 481-498
• 22 Richert H. Entwicklung eines magnetischen Monitoringsystems am Beispiel der nichtinvasiven Untersuchung des menschlichen Verdauungssystems. Jena Friedrich-Schiller Universität 2003; 100
• 23 Horowitz M, Wishart JM, Jones KL. et al. Gastric emptying in diabetes: an overview. Diabet Med 1996; 13: 16-22
• 24 Mojaverian P, Ferguson RK, Vlasses PH. et al. Estimation of gastric residence time of the Heidelberg capsule in humans: effect of varying food composition. Gastroenterology 1985; 89: 392-397
• 25 Cassilly D, Kantor S, Knight LC. et al. Gastric emptying of a non-digestible solid: assessment with simultaneous SmartPill pH and pressure capsule, antroduodenal manometry, gastric emptying scintigraphy. Neurogastroenterol Motil 2008; 20: 311-319
• 26 Samsom MRJJLMA. et al. Abnormalities of antroduodenal motility in type I diabetes. Diabetes Care 1996; 19: 21-27
• 27 Dooley CP, el Newihi HM, Zeidler A. et al. Abnormalities of the migrating motor complex in diabetics with autonomic neuropathy and diarrhea. Scand J Gastroenterol 1988; 23: 217-223
• 28 Eshraghian A, Eshraghian H. Interstitial cells of Cajal: A novel hypothesis for the pathophysiology of irritable bowel syndrome. Can J Gastroenterol 2011; 25: 277-279
• 29 Krishnan B, Babu S, Walker J. et al. Gastrointestinal complications of diabetes mellitus. World J Diabetes 2013; 4: 51-63
• 30 Bharucha AE, Batey-Schaefer B, Cleary PA. et al. Delayed gastric emptying is associated with early and long-term hyperglycemia in type 1 diabetes mellitus. Gastroenterology 2015; 149: 330-339
• 31 Rayner CK, Samsom M, Jones KL. et al. Relationships of upper gastrointestinal motor and sensory function with glycemic control. Diabetes Care 2001; 24: 371-381
• 32 Stern RM, Koch KL, Leibowitz HW. et al. Tachygastria and motion sickness. Aviat Space Environ Med 1985; 56: 1074-1077
• 33 Forster J, Damjanov I, Lin Z. et al. Absence of the interstitial cells of Cajal in patients with gastroparesis and correlation with clinical findings. J Gastrointest Surg 2005; 9: 102-108
• 34 Rosa-e-Silva L, Troncon LEA, Oliveira RB. et al. Rapid distal small bowel transit associated with sympathetic denervation in type I diabetes mellitus. Gut 1996; 39: 748-756
• 35 Faria M, Pavin EJ, Parisi MC. et al. Delayed small intestinal transit in patients with long-standing type 1 diabetes mellitus: investigation of the relationships with clinical features, gastric emptying, psychological distress, and nutritional parameters. Diabetes Technol Ther 2013; 15: 32-38
• 36 Smits MM, Tonneijck L, Muskiet MH. et al. Gastrointestinal actions of glucagon-like peptide-1-based therapies: glycaemic control beyond the pancreas. Diabetes Obes Metab 2016; 18: 224-235
• 37 Thazhath SS, Marathe CS, Wu T. et al. The glucagon-like peptide 1 receptor agonist exenatide inhibits small intestinal motility, flow, transit, and absorption of glucose in healthy subjects and patients with type 2 diabetes: A randomized controlled trial. Diabetes 2016; 65: 269-275